The Senate Human Services Committee convened on February 10, 2025, to discuss several key legislative proposals, primarily focusing on health insurance benefits related to insulin and diabetic supplies. The meeting began promptly at 9:00 AM and included discussions on Senate Bill 2370, which aims to expand a previous pilot program that capped insulin costs at $25 per month for members of the North Dakota Public Employees Retirement System (NDPERS) to the broader commercial insurance market.

Senator Sean Cleary, representing District 35, introduced Senate Bill 2370, highlighting its importance in improving affordability and accessibility for individuals requiring insulin. He noted that the pilot program had successfully saved members approximately $80 per month, with minimal impact on overall health plan premiums. The senator emphasized that the bill would provide consistency and predictability for those with varying insurance sources, thereby reducing the risk of rationing insulin due to cost.

The committee also heard from Rebecca Frikey, executive director of the Public Employees Retirement System, who supported the continuation of the insulin cap under the NDPERS plan. She clarified that while the PERS board recommended maintaining the cap for its members, it did not extend this recommendation to the entire commercial market. Frikey explained that the bill would primarily affect fully insured large employer groups, as self-funded plans are not regulated by the state.

Discussion among committee members included inquiries about the budget implications of continuing the insulin cap and the potential for expanding coverage to a larger segment of the population. Senator Hogan raised concerns about the sustainability of the pilot program and the need for legislative action to ensure its continuation beyond the current biennium.

The committee concluded the hearing on Senate Bill 2370 with a motion to pass the bill, which received unanimous support from the members present. The next steps involve further deliberation on the bill's implications and potential amendments as it moves through the legislative process.

Overall, the meeting underscored the committee's commitment to addressing healthcare affordability and accessibility, particularly for those dependent on insulin and diabetic supplies. The discussions set the stage for continued legislative efforts to enhance health insurance coverage in North Dakota.